Addiction. Mental and behavioral disorders due to use of other stimulants, including caffeine: dependence syndromes
Conditions
Interventions
Intervention 1: Intervention group: The group will receive duloxetine treatment in two months. Intervention 2: Control group: The control group will receive placebo treatment in two months.
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Gender Male Methamphetamine dependence diagnoses accordingly Diagnostic and Statistical Manual of Mental Disorders fifth edition The dominant use of methamphetamine for at least 6 months lack of serious psychiatric disorders
Exclusion criteria
Exclusion criteria: Gender female No use of other drugs and stimulants at the time of entering the study The absence of comorbid psychiatric disorders symptoms
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression. Timepoint: before intervention- 4 weeks later- 8 weeks later. Method of measurement: Depression Inventory.;Withdrawal symptoms. Timepoint: before intervention- 4 weeks later- 8 weeks later. Method of measurement: Inventory withdrawal symptoms.;Craving. Timepoint: before intervention- 4 weeks later- 8 weeks later. Method of measurement: Craving Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFaezeh Tatari
Kermanshah University of Medical Sciences
Outcome results
None listed